Olanzapine inhibits hepatic apolipoprotein A5 secretion inducing hypertriglyceridemia in schizophrenia patients and mice
Xiansheng Huang, Yiqi Zhang, Wenqiang Zhu, Piaopiao Huang, Jingmei Xiao, Yang Yang, Li Shen, Fei Luo, Wen Dai, Rong Li, Renrong Wu
doi: https://doi.org/10.1101/2021.02.26.21252514
Xiansheng Huang
1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Yiqi Zhang
2Department of Critical Care Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
Wenqiang Zhu
1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Piaopiao Huang
1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Jingmei Xiao
3National Clinical Research Center for Mental Disorders, and Department of Psychaitry, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China
Yang Yang
1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Li Shen
1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Fei Luo
1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
4Department of Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, The United States
Wen Dai
1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
5Department of Medicine, Columbia University Medical Center, New York, The United States
Rong Li
6Department of Stomatology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Renrong Wu
3National Clinical Research Center for Mental Disorders, and Department of Psychaitry, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China
Posted March 01, 2021.
Olanzapine inhibits hepatic apolipoprotein A5 secretion inducing hypertriglyceridemia in schizophrenia patients and mice
Xiansheng Huang, Yiqi Zhang, Wenqiang Zhu, Piaopiao Huang, Jingmei Xiao, Yang Yang, Li Shen, Fei Luo, Wen Dai, Rong Li, Renrong Wu
medRxiv 2021.02.26.21252514; doi: https://doi.org/10.1101/2021.02.26.21252514
Olanzapine inhibits hepatic apolipoprotein A5 secretion inducing hypertriglyceridemia in schizophrenia patients and mice
Xiansheng Huang, Yiqi Zhang, Wenqiang Zhu, Piaopiao Huang, Jingmei Xiao, Yang Yang, Li Shen, Fei Luo, Wen Dai, Rong Li, Renrong Wu
medRxiv 2021.02.26.21252514; doi: https://doi.org/10.1101/2021.02.26.21252514
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2318)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11653)
- Forensic Medicine (10)
- Gastroenterology (687)
- Genetic and Genomic Medicine (3656)
- Geriatric Medicine (344)
- Health Economics (625)
- Health Informatics (2340)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3407)
- Nursing (193)
- Nutrition (512)
- Oncology (1787)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (442)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6047)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (391)
- Toxicology (50)
- Transplantation (171)
- Urology (144)